Public Awareness Regarding Corticosteroid Use and Side Effects: A Cross-Sectional Study in Riyadh, Saudi Arabia
Abstract
:1. Introduction
2. Methods
2.1. Study Design and Settings
2.2. Sample Population
2.3. Questionnaire Tool
2.4. Questionnaire Translation
2.5. Face Validity Check and Piloting Phase
2.6. Sample Size
2.7. Statistical Analysis
2.8. Ethical Approval
3. Results
3.1. Participants’ Demographic Characteristics
3.2. Knowledge of the Administration Method and Indications of Use
3.3. Community’s Awareness of Side Effects
3.4. Corticosteroid Users’ Awareness of Side Effects, and Evaluating the Doctor’s Level of Awareness
3.5. Participants’ Sources of Information Regarding Corticosteroid Treatment
3.6. Predictors of Using Corticosteroids
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Adkins, C. Corticosteroids and Steroid Therapy: New Research; Nova Science Publishers, Incorporated: Hauppauge, NY, USA, 2015. [Google Scholar]
- Padda, I.; Parmar, M.S. Corticosteroids. In Hpd Books and Book Chapters; Wexler, P., Ed.; Elsevier: Amsterdam, The Netherlands, 2022. [Google Scholar]
- Liu, D.; Ahmet, A.; Ward, L.; Krishnamoorthy, P.; Mandelcorn, E.D.; Leigh, R.; Brown, J.P.; Cohen, A.; Kim, H. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin. Immunol. 2013, 9, 30. [Google Scholar] [CrossRef] [PubMed]
- Dey, V. Misuse of topical corticosteroids: A clinical study of adverse effects. Indian Dermatol Online J. 2014, 5, 436–440. [Google Scholar] [CrossRef]
- Ference, J.; Last, A.R. Choosing topical corticosteroids. Am. Fam. Physician 2009, 79, 135–140. [Google Scholar]
- Murr, A.H.; Smith, T.L.; Hwang, P.H.; Bhattacharyya, N.; Lanier, B.J.; Stambaugh, J.W.; Mugglin, A.S. Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent. Int. Forum. Allergy Rhinol. 2019, 1, 23–32. [Google Scholar] [CrossRef] [PubMed]
- Chaudhari, H.E.; Panchmiya, H.R.; Goyal, S.N.; Patil, S.R. Physicians perception towards corticosteroids as therapeutic agent: A survey. J. Pharm. Res. Clin. Pract. 2015, 5, 1–12. [Google Scholar]
- Sallam, A.; Hussain, N.; Khalidi, D.; Said, A. Knowledge, attitude, and practice analysis of corticosteroid use among patients: A study based in the united arab emirates. Natl. J. Physiol. Pharm. Pharmacol. 2017, 7, 562–568. [Google Scholar]
- Buchman, A.L. Side effects of corticosteroid therapy. J. Clin. Gastroenterol. 2001, 33, 289–294. [Google Scholar] [CrossRef]
- van Herpen-Meeuwissen, L.J.M.; van den Bemt, B.J.F.; Derijks, H.J.; van den Bemt, P.M.L.A.; Maat, B.; van Onzenoort, H.A.W. The effect of patient’s own medication use on patient’s self-reported medication knowledge during hospitalisation: A pre-post intervention study. BMC Health Serv. Res. 2022, 22, 423. [Google Scholar] [CrossRef]
- Bennadi, D. Self-medication: A current challenge. J. Basic Clin. Pharm. 2013, 5, 19–23. [Google Scholar] [CrossRef] [PubMed]
- Alsukait, S.F.; Alshamlan, N.A.; Alhalees, Z.Z.; Alsuwaidan, S.N.; Alajlan, A.M. Topical corticosteroids knowledge, attitudes, and practices of primary care physicians. Saudi Med. J. 2017, 38, 662–665. [Google Scholar] [CrossRef] [PubMed]
- Aubert-Wastiaux, H.; Moret, L.; Le Rhun, A.; Fontenoy, A.M.; Nguyen, J.M.; Leux, C.; Misery, L.; Young, P.; Chastaing, M.; Danou, N. Topical corticosteroid phobia in atopic dermatitis: A study of its nature, origins and frequency. Br. J. Dermatol. 2011, 165, 808–814. [Google Scholar] [CrossRef]
- Yakar, H.I.; Kanbay, A. Evaluation of corticophobia in asthmatic patients. Niger. J. Clin. Pract. 2020, 23, 1033–1038. [Google Scholar] [CrossRef]
- Ashique, K.T.; Kaliyadan, F.; Mohan, S.; Vijayan, S.; Chandrasekhar, D. Knowledge, attitudes and behavior regarding topical corticosteroids in a sample of pharmacy students: A cross sectional survey. Indian Dermatol. Online J. 2018, 9, 432–434. [Google Scholar] [CrossRef] [PubMed]
- Özçeker, D.; Uçkun, U.; İslamova, D.; Tamay, Z.; Güler, N. Corticosteroid phobia among parents of asthmatic children. Turk. J. Pediatr. 2018, 60, 142–146. [Google Scholar] [CrossRef]
- Moawad, S.; Mahé, E.; Aubert-Wastiaux, H.; Phan, A.; Maruani, A.; Chiaverini, C.; Bodemer, C.; Mazereeuw-Hautier, J.; Lasek-Duriez, A.; Droitcourt, C. Topical corticosteroid concerns among parents of children with psoriasis versus atopic dermatitis: A french multicenter cross-sectional study. Am. J. Clin. Dermatol. 2018, 19, 261–265. [Google Scholar] [CrossRef] [PubMed]
- El Hachem, M.; Gesualdo, F.; Ricci, G.; Diociaiuti, A.; Giraldi, L.; Ametrano, O.; Occella, C.; Fortina, A.B.; Milioto, M.; Arcangeli, F. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: A multicentre survey. Ital. J. Pediatr. 2017, 43, 22. [Google Scholar] [CrossRef] [PubMed]
- Sekler, O.; Segev-Becker, A.; Interator, H.; Brener, A.; Schachter-Davidov, A.; Elkon-Tamir, E.; Lebenthal, Y. Paediatricians’ practices and knowledge of corticosteroids: A national survey. Acta Paediatr. 2021, 110, 711–717. [Google Scholar] [CrossRef] [PubMed]
- Van Paassen, J.; Vos, J.S.; Hoekstra, E.M.; Neumann, K.M.I.; Boot, P.C.; Arbous, S.M. Corticosteroid use in covid-19 patients: A systematic review and meta-analysis on clinical outcomes. Crit. Care 2020, 24, 696. [Google Scholar] [CrossRef]
- Costello, R.; Patel, R.; Humphreys, J.; McBeth, J.; Dixon, W.G. Patient perceptions of glucocorticoid side effects: A cross-sectional survey of users in an online health community. BMJ Open 2017, 7, e014603. [Google Scholar] [CrossRef]
- Hodgens, A.; Sharman, T. Corticosteroids. In Statpearls [Internet]; StatPearls Publishing: St. Petersburg, FL, USA, 2022. [Google Scholar]
- Coutinho, A.E.; Chapman, K.E. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol. Cell. Endocrinol. 2011, 335, 2–13. [Google Scholar] [CrossRef]
- Peat, I.D.; Healy, S.; Reid, D.M.; Ralston, S.H. Steroid induced osteoporosis: An opportunity for prevention? Ann. Rheum. Dis. 1995, 54, 66–68. [Google Scholar] [CrossRef] [PubMed]
- Van Staa, T.-P.; Leufkens, H.G.M.; Abenhaim, L.; Begaud, B.; Zhang, B.; Cooper, C. Use of oral corticosteroids in the united kingdom. Qjm 2000, 93, 105–111. [Google Scholar] [CrossRef] [PubMed]
- Lau, W.M.; Donyai, P. Knowledge, attitude and advice-giving behaviour of community pharmacists regarding topical corticosteroids. Pharmacy 2017, 5, 41. [Google Scholar] [CrossRef] [PubMed]
- Seo, H.; Song, S.Y.; Kim, D.; Park, J.H.; Shin, Y.; Lee, K.H.; Choi, S.A.; Lee, J.-Y.; Shin, W.G.; Kim, E. General public knowledge regarding topical corticosteroids: A nationwide survey in south korea. Korean Coll. Clin. Pharm. 2022, 32, 84–92. [Google Scholar] [CrossRef]
- Shetty, Y.C.; Vinchurkar, P.; More, S.; Siddiqui, A.; Tilak, S.; Ginodia, S.; Jinturkar, S.; Pancholi, V.; Nair, N.; Goyal, R. Knowledge and awareness regarding corticosteroids and effectiveness of a novel steroid educational module among people visiting general opd of a tertiary care hospital. Indian J. Pharm. Pract. 2022, 15, 40–45. [Google Scholar] [CrossRef]
- Barakat, M.; Elnaem, M.H.; Al-Rawashdeh, A.; Othman, B.; Ibrahim, S.; Abdelaziz, D.H.; Alshweiki, A.O.; Kharaba, Z.; Malaeb, D.; Syed, N.K. Assessment of knowledge, perception, experience and phobia toward corticosteroids use among the general public in the era of covid-19: A multinational study. Healthcare 2023, 11, 255. [Google Scholar] [CrossRef]
- Fathima, F.; Roy, A. Awareness of adverse effects of corticosteroids among dental undergraduates: A survey. Int. J. Sci. Res. 2017, 6, 926–928. [Google Scholar]
- AlDhabbah, O.M.; AlJutayli, Z.A.; AlObaid, A.S.; AlOraini, T.A.; Alsaif, A.K.; Elmorsy, E.A. Awareness of corticosteroids’ side effects among attendees in king fahad specialist hospital, buraydah city, saudi arabia. Int. J. Med. Dev. Ctries 2021, 5, 1686–1694. [Google Scholar] [CrossRef]
- Ventola, C.L. Social media and health care professionals: Benefits, risks, and best practices. Pharm. Ther. 2014, 39, 491–520. [Google Scholar]
- Lambert, K.M.; Barry, P.; Stokes, G. Risk management and legal issues with the use of social media in the healthcare setting. J. Healthc. Risk Manag. 2012, 31, 41–47. [Google Scholar] [CrossRef]
- Gray, N.J.; Boardman, H.F.; Symonds, B.S. Information sources used by parents buying non-prescription medicines in pharmacies for preschool children. Int. J. Clin. Pharm. 2011, 33, 842–848. [Google Scholar] [CrossRef] [PubMed]
- Khalifeh, M.; Moore, N.; Salameh, P. Social knowledge and attitude toward over-the-counter drug use. Am. J. Clin. Med. Res. 2018, 6, 35–40. [Google Scholar] [CrossRef]
- Charman, C.R.; Morris, A.D.; Williams, H.C. Topical corticosteroid phobia in patients with atopic eczema. Br. J. Dermatol. 2000, 142, 931–936. [Google Scholar] [CrossRef] [PubMed]
- Interactive, H. Attitudes and Beliefs about the Use of Over-the-Counter Medicines: A Dose of Reality; National Council on Patient Information and Education: Rockville, MD, USA, 2002; pp. 1–76. [Google Scholar]
- Herbig, B.; Dragano, N.; Angerer, P. Health in the long-term unemployed. Dtsch. Ärzteblatt Int. 2013, 110, 413. [Google Scholar] [CrossRef] [PubMed]
- Li, K.; Lorgelly, P.; Jasim, S.; Morris, T.; Gomes, M. Does a working day keep the doctor away? A critical review of the impact of unemployment and job insecurity on health and social care utilisation. Eur. J. Health Econ. 2023, 24, 179–186. [Google Scholar] [CrossRef]
- Yuan, F.; Qian, D.; Huang, C.; Tian, M.; Xiang, Y.; He, Z.; Feng, Z. Analysis of awareness of health knowledge among rural residents in western china. BMC Public Health 2015, 15, 55. [Google Scholar] [CrossRef]
- Case, A.; Lubotsky, D.; Paxson, C. Economic status and health in childhood: The origins of the gradient. Am. Econ. Rev. 2002, 92, 1308–1334. [Google Scholar] [CrossRef]
- Robert, S.A. Community-level socioeconomic status effects on adult health. J. Health Soc. Behav. 1998, 39, 18–37. [Google Scholar] [CrossRef]
- Alkhatim, W.A.S. Awareness of oral corticosteroid use among sudanese with rheumatological diseases: A single centre study. Sch. Acad. J. Pharm. 2021, 3, 49–53. [Google Scholar] [CrossRef]
Variable | Frequency | Percentage | Frequency | Percentage | Frequency | Percentage | p-Value |
---|---|---|---|---|---|---|---|
Overall | Users | Non-Users | |||||
Age categories | |||||||
18–20 years | 106 | 14.5% | 24 | 11.9% | 82 | 15.5% | 0.040 |
21–30 years | 236 | 32.2% | 55 | 27.2% | 181 | 34.2% | |
31–40 years | 194 | 26.5% | 53 | 26.2% | 141 | 26.6% | |
41–50 years | 109 | 14.9% | 43 | 21.3% | 66 | 12.5% | |
51–60 years | 71 | 9.7% | 22 | 10.9% | 49 | 9.2% | |
61 years and above | 16 | 2.2% | 5 | 2.5% | 11 | 2.1% | |
Gender | |||||||
Males | 366 | 50.0% | 74 | 36.6% | 292 | 55.1% | <0.001 |
Nationality | |||||||
Saudi | 677 | 92.5% | 183 | 90.6% | 494 | 93.2% | 0.149 |
Education | |||||||
Primary school or lower | 5 | 0.7% | 5 | 2.5% | 0 | 0.0% | 0.005 |
Intermediate school | 9 | 1.2% | 4 | 2.0% | 5 | 0.9% | |
Secondary school | 204 | 27.9% | 45 | 22.6% | 159 | 30.0% | |
Bachelor’s degree | 446 | 60.9% | 121 | 60.8% | 325 | 61.3% | |
Higher education | 68 | 9.3% | 27 | 13.6% | 41 | 7.7% | |
Employment | |||||||
Student | 207 | 28.3% | 50 | 24.8% | 157 | 29.6% | 0.015 |
Employed (governmental sector) | 172 | 23.5% | 46 | 22.8% | 88 | 16.6% | |
Employed (private sector) | 180 | 24.6% | 15 | 7.4% | 24 | 4.5% | |
Unemployed | 134 | 18.3% | 37 | 18.3% | 143 | 27.0% | |
Retired | 39 | 5.3% | 54 | 26.7% | 118 | 22.3% | |
Marital status | |||||||
Married | 336 | 45.9% | 116 | 57.4% | 220 | 41.5% | <0.001 |
Single | 364 | 49.7% | 75 | 37.1% | 289 | 54.5% | |
Divorced | 25 | 3.4% | 9 | 4.5% | 16 | 3.0% | |
Widowed | 7 | 1.0% | 2 | 1.0% | 5 | 0.9% |
Variable | Frequency | Percentage |
---|---|---|
In your opinion, how can corticosteroid treatment be given? (You can choose more than one option) | ||
Orally | 437 | 59.7% |
Topically | 365 | 49.9% |
Intravenous injection | 319 | 43.6% |
Inhalation | 227 | 31.0% |
Intramuscular injection | 176 | 24.0% |
Eye drops | 164 | 22.4% |
Articular injection | 136 | 18.6% |
Dermal injection | 111 | 15.2% |
Rectally | 59 | 8.1% |
In your opinion, what are the cases that require corticosteroid treatment? (You can choose more than one option) | ||
Asthma | 363 | 49.6% |
Rheumatoid disease | 347 | 47.4% |
Severe allergy | 304 | 41.5% |
Inflammation of the joints, muscles and tendons | 295 | 40.3% |
Lupus | 204 | 27.9% |
Chronic obstructive pulmonary disease | 173 | 23.6% |
Joint stiffness | 161 | 22.0% |
Ulcer | 137 | 18.7% |
Kidney stone | 128 | 17.5% |
Recurrent gastrointestinal infections (Crohn’s and ulcerative colitis) | 105 | 14.3% |
Blood cancer (leukaemia) | 99 | 13.5% |
Glomerulonephritis | 98 | 13.4% |
Adrenal insufficiency—Addison’s disease | 86 | 11.7% |
Lymphomas | 85 | 11.6% |
Cardiovascular diseases | 77 | 10.5% |
Diabetes mellitus | 77 | 10.5% |
Hypertension | 72 | 9.8% |
Mental illnesses (anxiety and depression) | 62 | 8.5% |
Dyslipidaemia | 57 | 7.8% |
Cushing’s syndrome | 56 | 7.7% |
Gastroesophageal reflux disease. | 48 | 6.6% |
Erectile dysfunction | 43 | 5.9% |
Variable | Frequency | Percentage |
---|---|---|
In your opinion, which of the following is a side effect of corticosteroid treatment? (You can choose more than one option) | ||
Weight gain | 325 | 44.4% |
Skin changes (e.g., bruising, tender skin, stretch marks, redness of the face) | 222 | 30.3% |
Fluid accumulation in the body with difficulty breathing | 203 | 27.7% |
Acne/pimples on the face | 202 | 27.6% |
Mood changes | 188 | 25.7% |
Heart palpitations and heart attack | 161 | 22.0% |
Osteoporosis | 160 | 21.9% |
High blood sugar level | 151 | 20.6% |
Face roundness | 142 | 19.4% |
Eye diseases (e.g., white water, glaucoma) | 133 | 18.2% |
Depression | 123 | 16.8% |
Hair loss | 117 | 16.0% |
Hypertension | 114 | 15.6% |
Diarrhea | 110 | 15.0% |
Anorexia | 108 | 14.8% |
Palpitations | 108 | 14.8% |
Infection (e.g., pneumonia) | 106 | 14.5% |
Insomnia | 96 | 13.1% |
Constipation | 85 | 11.6% |
Indigestion | 81 | 11.1% |
Cold extremities | 75 | 10.2% |
Anemia | 64 | 8.7% |
Decreased daily urination | 57 | 7.8% |
Erectile dysfunction | 48 | 6.6% |
Memory loss | 47 | 6.4% |
Epilepsy | 34 | 4.6% |
Variable | Frequency | Percentage |
---|---|---|
Have you ever taken corticosteroid treatment? | ||
Yes | 202 | 27.6% |
During your diagnosis/treatment, did you receive verbal or written information from your doctor regarding the side effects of corticosteroid treatment? (n = 202) | ||
Yes | 83 | 41.1% |
No | 63 | 31.2% |
I don’t remember | 56 | 27.7% |
Did you experience any of these side effects while taking corticosteroids? (You can choose more than one option) (n = 202) | ||
Weight gain | 77 | 38.1% |
Mood changes | 52 | 25.7% |
Skin changes (e.g., bruising, thinning skin, stretch marks) | 44 | 21.8% |
Acne/pimples on the face | 37 | 18.3% |
palpitations | 36 | 17.8% |
Insomnia | 31 | 15.3% |
Face roundness (moon face) | 31 | 15.3% |
Indigestion | 20 | 9.9% |
Hypertension | 18 | 8.9% |
Osteoporosis | 18 | 8.9% |
Eye diseases (e.g., white water, glaucoma) | 16 | 7.9% |
High blood glucose level | 14 | 6.9% |
Infection (ex: pneumonia) | 11 | 5.4% |
Cardiovascular diseases (ex: heart attack) | 9 | 4.5% |
Variable | Frequency | Percentage |
---|---|---|
What are your sources of information about corticosteroid treatment? (You can choose more than one option) | ||
Friends and family | 333 | 45.5% |
Healthcare providers | 284 | 38.8% |
Social media | 211 | 28.8% |
Medical websites | 175 | 23.9% |
Public websites | 96 | 13.1% |
Magazines and books | 59 | 8.1% |
Variable | Odds Ratio of Using Corticosteroids (95% Confidence Interval) | p-Value |
Age categories | ||
18–20 years (reference group) | 1.00 | |
21–30 years | 1.04 (0.60–1.79) | 0.893 |
31–40 years | 1.28 (0.74–2.23) | 0.376 |
41–50 years | 2.23 (1.23–4.04) | 0.008 |
51–60 years | 1.53 (0.78–3.02) | 0.216 |
61 years and above | 1.55 (0.49–4.91) | 0.453 |
Gender | ||
Females (reference group) | 1.00 | |
Males | 0.47 (0.34–0.66) | <0.001 |
Education | ||
Higher education (reference group) | 1.00 | |
Secondary school | - | - |
Intermediate school | 0.43 (0.24–0.77) | 0.005 |
Bachelor’s degree | 1.22 (0.30–4.93) | 0.786 |
Primary school or lower | 0.57 (0.33–0.96) | 0.035 |
Employment | ||
Student (reference group) | 1.00 | |
Unemployed | 1.64 (1.02–2.65) | 0.042 |
Retired | 1.96 (0.96–4.03) | 0.066 |
Employed (private sector) | 0.81 (0.50–1.32) | 0.398 |
Employed (governmental sector) | 1.44 (0.91–2.26) | 0.117 |
Marital status | ||
Widowed (reference group) | 1.00 | |
Single | 0.65 (0.12–3.41) | 0.609 |
Married | 1.32 (0.25–6.90) | 0.744 |
Divorced | 1.41 (0.23–8.78) | 0.715 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Qutob, R.A.; Alhusaini, B.A.; Aljarba, N.K.; Alzaid, O.N.; Aljahili, N.A.; Alzahrani, K.S.; Sharaf, M.M.; Alghamdi, A.H.; Alaryni, A.A.; Alammari, Y.M.; et al. Public Awareness Regarding Corticosteroid Use and Side Effects: A Cross-Sectional Study in Riyadh, Saudi Arabia. Healthcare 2023, 11, 2747. https://doi.org/10.3390/healthcare11202747
Qutob RA, Alhusaini BA, Aljarba NK, Alzaid ON, Aljahili NA, Alzahrani KS, Sharaf MM, Alghamdi AH, Alaryni AA, Alammari YM, et al. Public Awareness Regarding Corticosteroid Use and Side Effects: A Cross-Sectional Study in Riyadh, Saudi Arabia. Healthcare. 2023; 11(20):2747. https://doi.org/10.3390/healthcare11202747
Chicago/Turabian StyleQutob, Rayan Abubakker, Bassam Abdulaziz Alhusaini, Najd Khalid Aljarba, Omar Nasser Alzaid, Nawaf Abdulaziz Aljahili, Khalid Saad Alzahrani, Mohammed Mahmoud Sharaf, Abdullah Hussien Alghamdi, Abdullah Abdulaziz Alaryni, Yousef Mohammed Alammari, and et al. 2023. "Public Awareness Regarding Corticosteroid Use and Side Effects: A Cross-Sectional Study in Riyadh, Saudi Arabia" Healthcare 11, no. 20: 2747. https://doi.org/10.3390/healthcare11202747
APA StyleQutob, R. A., Alhusaini, B. A., Aljarba, N. K., Alzaid, O. N., Aljahili, N. A., Alzahrani, K. S., Sharaf, M. M., Alghamdi, A. H., Alaryni, A. A., Alammari, Y. M., Alanazi, A. M., Faqihi, F. A., Al Harbi, K. M., Alsolamy, E. N., & Hakami, O. A. (2023). Public Awareness Regarding Corticosteroid Use and Side Effects: A Cross-Sectional Study in Riyadh, Saudi Arabia. Healthcare, 11(20), 2747. https://doi.org/10.3390/healthcare11202747